Evidence Details for UQCR10

Basic Information
Top
Gene Symbol: | UQCR10 ( HSPC051,HSPC151,QCR9,UCCR7.2,UCRC ) |
---|
Gene Full Name: | ubiquinol-cytochrome c reductase, complex III subunit X |
---|
Band: | 22q12.2 |
---|
Quick Links | Entrez ID:29796; OMIM: 610843; Uniprot ID:QCR9_HUMAN; ENSEMBL ID: ENSG00000184076; HGNC ID: 30863 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
>UQCR10|29796|nucleotide
ATGGCGGCCGCGACGTTGACTTCGAAATTGTACTCCCTGCTGTTCCGCAGGACCTCCACCTTCGCCCTCACCATCATCGTGGGCGTCATGTTCTTCGAGCGCGCC
TTCGATCAAGGCGCGGACGCTATCTACGACCACATCAACGAGGGGGTGAGGGCCTGTGCCATCCCTGACCTTGGACCCGCCTGA
« Hide>UQCR10|29796|nucleotide
ATGGCGGCCGCGACGTTGACTTCGAAATTGTACTCCCTGCTGTTCCGCAGGACCTCCACCTTCGCCCTCACCATCATCGTGGGCGTCATGTTCTTCGAGCGCGCC
TTCGATCAAGGCGCGGACGCTATCTACGACCACATCAACGAGGGGGTGAGGGCCTGTGCCATCCCTGACCTTGGACCCGCCTGA
Show »>UQCR10|29796|protein
MAAATLTSKLYSLLFRRTSTFALTIIVGVMFFERAFDQGADAIYDHINEGVRACAIPDLGPA
« Hide>UQCR10|29796|protein
MAAATLTSKLYSLLFRRTSTFALTIIVGVMFFERAFDQGADAIYDHINEGVRACAIPDLGPA
Show » 
Evidence summary
Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default. 
Syndromic Autism Gene
Top

Genome-Wide Association Studies(By Ethnic Group)
Top
Family Based Association Studies: 0
Reference |
Stage |
Platform |
#Families |
Affecteds |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ (range) |
No Evidence. |
Case Control Based Association Studies: 0
Reference |
Stage |
Platform |
ASD Cases |
Normal Controls |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ |
#Subjects (% Women) |
Age (range) |
No Evidence. |

CNV Studies
Top
Reference |
Source |
Method |
ADI-R |
ADOS |
Diagnosis |
Family |
Individual |
Total |
Simplex |
Multiplex |
Control |
Affected |
Control |
Total |
No matched CNVs ! |

Linkage Studies
Top
Reference |
Source |
Method |
ADI-R |
ADOS |
Diagnosis |
Family |
Individual |
Total |
Simplex |
Multiplex |
Control |
Affected |
Control |
Total |
No Matched Linkage Regions ! |

Low Scale Association Studies (by Ethnic Group)
Top
Family Based Association Studies: 0
Reference |
Source |
Platform |
#Families |
Affecteds |
Result |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ (range) |
No Evidence. |
Case Control Based Association Studies: 0
Reference |
Source |
Platfrom |
ASD Cases |
Normal Controls |
Result |
ADI-R |
ADOS |
Diagnosis |
Age (range) |
IQ |
#Subjects (% Women) |
Age (range) |
No Evidence. |

Large Scale Expression Studies
Top
Microarray Studies: 1
Reference |
Source |
Tissue |
#Subjects (% Women) |
ADI-R |
ADOS |
Endo- pheno |
Diagnosis |
Normal Controls (% Women) |
Fold Change |
Up/ Down |
P/Q value |
Voineagu, 2011_1 |
Unknown |
16 frontal cortex(BA9) and 13 temporal cortex(BA41 |
16 (25.00%) |  |  | - | autism |
16 (6.25%) |
0.930511 |
Down |
4.16982 | |
- Platform: Illumina Ref8 v3 microarrays
- ProbeSet: ILMN_2366710
- RefSeq_ID/ EST: -
- GEO_ID: GSE28521
- Statistic Method: SAM package and unless otherwise specified the significance threshold was FDR,0.05 and fold changes.1.3.
|
Proteomics Studies:0
Reference |
Source |
Tissue |
Platform |
#Subjects (% Women) |
ADI-R |
ADOS |
Diagnosis |
Normal Controls(% Women) |
No Evidence. |

NGS
de novo Mutation Studies
Top
Reference |
Case Number |
Family Number |
de novo Number |
Title |
No matched NGS de novo Mutation Studies! |

NGS Mosaic SNV Studies
Top
Reference |
Case Number |
Family Number |
Mosaic Number |
Title |
No matched NGS Mosaic SNVs! |

NGS Other Studies
Top
Reference |
Source |
Platform |
ADI-R |
ADOS |
Diagnosis |
Family |
Affected |
Validation Method |
Total |
Simplex |
Multiplex |
No matched NGS Other Studies! |

Low Scale Gene Studies
Top
Abbreviations: AD, autistic disorder; ASD: autism spectrum disorder.
Reference |
Organism |
Tissue |
ADI-R |
ADOS |
Diagnosis |
Evidence Level |
Result |
No Evidence. |
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.